Article
Envision Pharma Group
Leveraging Real-World Evidence (RWE) in MSL Activities
Summary
This week's guest is Elizabeth Pash, Medical Affairs Executive Leader who shares insights on how to leverage real-world evidence (RWE) in MSL activities.
Key Points
- MSLs play a crucial role in leveraging real world evidence (RWE) to enhance the understanding of medical treatments and interventions beyond traditional clinical trials.
- The increasing acceptance of RWE, driven by legislative changes like the 21st Century Cures Act, highlights its growing importance in regulatory submissions and decision-making processes.
- Effective communication of RWE requires MSLs to tailor their presentations to different stakeholders, including healthcare providers, payers, and patients, while ensuring compliance with regulatory standards.
real-world evidence, MSL activities, medical affairs, regulatory submissions, healthcare communication
Related Topics
You May Also Like
Envision Pharma Group
Article
Envision Pharma Group
Medical affairs: The power behind redefining commercialization
Article
E Dawn Flick, Howard R Terebelo, Susan Fish, Amani Kitali, Vrinda Mahajan, Melissa Nifenecker, Kristen Sullivan, Paul Thaler, Sarah Ussery, David L Grinblatt
The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research
Article
Robbe Saesen, Mieke Van Hemelrijck, Jan Bogaerts, Christopher M. Booth, Jan J. Cornelissen, Andre Dekker, Elizabeth A. Eisenhauer, André Freitas, Alessandro Gronchi, Miguel A. Hernán, Frank Hulstaert, Piet Ost, Petr Szturz, Helena M. Verkooijen, Michael W
Defining the role of real-world data in cancer clinical research: The position of the
Podcast
MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper
The Struggle With KOL Access in Todays World
Podcast
MSL Talk: Tom Caravela, Daniel Snyder